HYFT Financial Model
Quarterly and annual income statement, cash flow and balance sheet line items for ImmunoPrecise Antibodies Ltd.: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Jul 31, 2026.